Clinical Trials Logo

Hematuria clinical trials

View clinical trials related to Hematuria.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05362539 Completed - Bladder Cancer Clinical Trials

Novel Urine-Based DNA Methylation Biomarkers for Urothelial Bladder Carcinoma Detection in Patients With Hematuria

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

The current study aimed to assess the diagnostic performance of novel urine-based DNA hypermethylation of six genes (GATA4, P16, P14, APC, CDH1 and CD99) for UBC detection in patients with hematuria.

NCT ID: NCT05314582 Completed - Hematuria Clinical Trials

Anticoagulant/Antiaggregant Use and Postoperative Bleeding Risk in Patients With Bladder Tumor and Benign Prostatic Hyperplasia

Start date: March 10, 2022
Phase:
Study type: Observational [Patient Registry]

Patients who were using anticoagulant or antiaggregant medications for any reason and underwent transurethral resection of bladder tumor (TUR-BT) or transurethral resection of the prostate (TURP) or open prostatectomy (OP) due to BPH will be compared with those who were not using anticoagulant or antiplatelet medication. The rates of postoperative clot retention, presence of hematuria, reoperation due to hematuria, blood transfusion and re-admissions due to hematuria in the first postoperative month will be compared.

NCT ID: NCT05011253 Completed - Hematuria Clinical Trials

Electronic Triggers: Microhematuria Trigger

Start date: October 6, 2021
Phase: N/A
Study type: Interventional

The research team will evaluate the effectiveness of an InBasket Results message that prompts providers to place appropriate follow up orders.

NCT ID: NCT04971057 Completed - Pain Clinical Trials

Multimedia Information for Patients With Renal Biopsy

Start date: December 14, 2019
Phase: N/A
Study type: Interventional

This study takes place in the Divisions of Nephrology. Patients undergoing renal biopsy were randomized to control group or multimedia information intervention group. The control group received routine care, and the multimedia information intervention group received a multimedia information. After the pre-test, the two groups performed the 1 to 3 post-tests on pre-operation, post-operative day 1 and post-operative day 9. This study used questionnaires that including General Self-Efficacy Scale, Pain Visual Analogy Scale, Visual Analogue Scale for Anxiety, and Positive and Negative Affective Scale.

NCT ID: NCT04555343 Completed - Prostate Cancer Clinical Trials

Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention

Start date: March 1, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

A study looking at the feasibility of doing a full-scale RCT that investigates the use of tranexamic acid intravesically prior to continuous bladder irrigation treatment in the emergency department for urinary retention due to clots. We want to know: - patient experience and acceptability of the intervention - study procedures (recruitment, site appropriateness, staff engagement) - safety data - identify resource use

NCT ID: NCT04317261 Completed - Bladder Cancer Clinical Trials

Role of Novel Urinary Genomic and Metablomic Markers in Diagnosis of Bladder Cancer in Patients With Hematuria

Start date: March 1, 2018
Phase: N/A
Study type: Interventional

Our goal is to develop a noninvasive, fast and simple assay to detect BCa on the GeneXpert system and metablomic genes.

NCT ID: NCT04275297 Completed - Clinical trials for Interstitial Cystitis

Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome

Start date: July 13, 2020
Phase: N/A
Study type: Interventional

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a severe pain condition affecting 3-8 million people in the United States lacking treatments that work. Emotional suffering is common in IC/BPS and known to make physical symptoms worse, and studies show patient sub-groups respond differently to treatment. By creating and testing a psychosocial intervention specific to IC/BPS, we will learn if this intervention improves patient wellness, who the intervention works best for, and how the body's pain processing influences outcomes.

NCT ID: NCT04077359 Completed - Clinical trials for Renal Cell Carcinoma

Prospective Trial for Examining Hematuria Using Computed Tomography

PROTEHCT
Start date: September 15, 2019
Phase: N/A
Study type: Interventional

The primary objective is to evaluate whether one-phase nephrographic CT (experimental) is sufficient to detect urothelial cell carcinoma in patients with hematuria compared to the traditional four-phase CT (control).

NCT ID: NCT03408288 Completed - Hematuria Clinical Trials

Value of an Integral Color Scale on Urine Collection Bags Versus Use of a Strip in Description of Hematuria.

HEMAPOCHE
Start date: January 16, 2018
Phase:
Study type: Observational

The investigators hypothesize that incorporation of a colorimetric scale on urine collection bags to estimate degree of hematuria would allow better characterization of urine by healthcare staff thus leading to improved patient care.

NCT ID: NCT03257293 Completed - Bladder Cancer Clinical Trials

A Trial of a Modified Cystoscopy Method to Reduce Pain Perception

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

The goal of this project is to improve patient experience of cystoscopy using a non-pharmacologic modification of procedure. Cystoscopy is a common outpatient procedure for urology patients and is usually performed without sedation. However, there is limited research into reduction of patient discomfort throughout this procedure. The proposed modification technique was selected based on a well-documented psychological phenomenon in which only particular moments over the course of an aversive event determine the resultant perception of the experience. It is hypothesized that implementation of the technique will decrease the recalled pain intensity of the cystoscopy.